Dopamine agonist modifies cortical activity in Parkinson disease: a functional neuroimaging study

Clin Neuropharmacol. 2014 Nov-Dec;37(6):166-72. doi: 10.1097/WNF.0000000000000052.

Abstract

Objectives: To investigate, using functional magnetic resonance imaging, the influence of a long-term dopaminergic therapy on brain activation during a simple motor task in early, previously untreated patients with Parkinson disease.

Methods: Thirteen patients with Parkinson disease in Hoehn-Yahr stage 1 or 2, with a right predominance of the disease, underwent functional magnetic resonance imaging during self-paced continuous right-hand tapping before and after 6 months of therapy with ropinirole 15 mg/d. The task was monitored online with a dedicated device, which measures the strength and frequency of the tapping.

Results: All patients with Parkinson disease on ropinirole treatment showed a clinically significant improvement, and their functional magnetic resonance imaging pattern after treatment showed a reduced activation in the right postcentral (primary sensory-motor area), supramarginal and inferior parietal gyri compared with the activation pattern before treatment. No area of increased activation was observed after therapy.

Conclusions: In line with the classical functional deafferentation hypothesis, dopaminergic stimulation should increase motor cortex activity as a result of restoration of the striatocortical loops. On the contrary, our results challenge this hypothesis as we found decreased cerebral activity after a short-term chronic dopaminergic treatment. We suggest that the recruitment of cortical motor circuits aimed to overcome the functional deficit of the striatocortical loops lessens after dopaminergic treatment.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / physiology
  • Dopamine Agonists / pharmacology*
  • Dopamine Agonists / therapeutic use
  • Female
  • Functional Neuroimaging*
  • Humans
  • Indoles / pharmacology*
  • Indoles / therapeutic use
  • Magnetic Resonance Imaging*
  • Male
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology*
  • Psychomotor Performance / drug effects
  • Psychomotor Performance / physiology

Substances

  • Dopamine Agonists
  • Indoles
  • ropinirole